Lipocine is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Mahesh V. Patel, with a market cap of $15.3M.
Common questions about Lipocine
Lipocine is scheduled to report earnings for Q1 2026 on May 7, 2026. Analysts estimate revenue of $137.5K.
Lipocine has approximately 17 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.